Chronic renal failure, kidney transplant, exercise tolerance, muscle strength, lung function, quality of life.
Conditions
Interventions
Control Group was composed of 30 individuals, where the guidelines were taken once a day by a physiotherapist, in the afternoon. Consisted of: general guidelines as to the breathing exercises associat
Other
E02.190.525.186
E02.779.483.875
Sponsors
Universidade Federal de São Paulo - UNIFESP
Universidade Cidade de São Paulo - UNICID
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients undergoing living donor kidney transplant; Any sex; Age 18 to 60 years.
Exclusion criteria
Exclusion criteria: Age 18 to 60 years; Any sex; Time of invasive mechanical ventilation longer than 24 hours post-transplant; Stay in the intensive care unit, ICU, for a period longer than 48 hours; Cognitive interfering in the techniques to be instituted; Pulmonary and cardiovascular complications in 24 hours after renal transplantation, such as pneumonia, pneumothorax, myocardial infarction, unstable angina, deep vein thrombosis and / or pulmonary embolism; Patients who underwent surgical intervention; Patients who present contraindications for testing the six-minute walk: orthopedic impairments, unstable angina and acute myocardial infarction in the last month, heart rate (HR) greater than 120 bpm at rest, systolic blood pressure greater than 180 mmHg or diastolic greater than 100 mmHg; Intraoperative death.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intervention group will present at the time of hospital discharge, the greater gain of respiratory muscle strength (MIP and MEP) compared to the control group. Respiratory muscle strength will be performed by measuring the maximal inspiratory pressure and maximal expiratory pressure. For this measurement will be used a digital manometer MVD-300 Globalmed brand. ;In the intervention group, a higher gain repiratória muscle strength at the time of hospital discharge, only MIP was observed when compared to the control group, which was verified by the manometer, based on the statement of a variation of at least 5% in pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Days of hospitalization.;There was no significant difference between the days of hospitalization in the control group and intervention group, which was verified by the number of days of hospitalization of each patient, based on the statement of a variation of at least 5% in pre and post measurements intervention. Average of 7.1 days of hospitalization for GC and 6.7 days for GI. | — |
Countries
Brazil
Contacts
Public ContactLeonardo;Luciana Costa;Chiavegato
Universidade Cidade de São Paulo - UNICID;Universidade Cidade de São Paulo - UNICID
Outcome results
None listed